The Direct to Consumer Laboratory Testing Market is projected to reach $14.61 billion by 2029, at a CAGR of 21.2% during the forecast period 2022–2029. Easy accessibility of DTC tests, the growing awareness regarding family health history and predictive testing, the increasing need for early disease diagnosis, the increasing prevalence of chronic and infectious diseases, and the rising geriatric population that prefers convenient care are expected to propel the global DTC laboratory testing market. Moreover, the adoption of telehealth is creating growth opportunities for this market.
However, the sample integrity and interference issues are restraining the market growth. Additionally, misinterpretation of test results and genetic data privacy concerns pose challenges to the growth of this segment.
Impact of COVID-19 on DTC Laboratory Testing Market
Due to the travel restrictions, self-isolation, and risk of getting infections from the test centers and hospitals, there was an increased demand for at-home kits. The DTC testing laboratories provided tests for consumers to fight against the COVID-19 pandemic. Furthermore, as the number of COVID-19 cases increased, the testing burden fell upon existing technologies such as PCR, arising the need for exploring and innovating other technologies for diagnostics. Several DTC lab testing companies focused on rapid multiplex and immunological tests and new sampling technologies for innovation in DTC testing, leading to the growth of the DTC lab testing market through the pandemic. For instance, in September 2021, Thermo Fisher Scientific, Inc. (U.S.) launched a stabilized saliva collection kit, SpeciMAX. This kit preserves viral nucleic acids in a non-hazardous stabilization solution that inactivates common respiratory viruses for safer sample collection
Increasing Awareness Regarding Predictive Testing and Family Health History Drive the Growth of the DTC Laboratory Testing Market
Predictive testing uses genetic samples of an asymptomatic individual to predict the risk of diseases in the future. This test aims to identify individuals at risk of specific conditions and to reduce mortality and morbidity through timely screening, surveillance, and prevention. For instance, in 2022, the WHO reported that non-communicable or chronic diseases account for 74% of deaths globally every year. Heart disease is one of the leading factors of mortality. In the U.S., in 2022, around 697,000 people died due to heart disease (Source: CDC). Moreover, the CDC states that about half of the people in the U.S. have at least 1 out of 3 risk factors for heart disease. Such high-risk factors and the benefits of predictive testing play a pivotal role in the increasing use of DTC tests.
Conventional diagnostic testing has medical importance only for the tested (except for infectious diseases). Predictive testing is directly related to family members. Concerns of family members also motivate an individual to undergo predictive testing. Moreover, if an individual has a family health history of chronic diseases, such as cancer, diabetes, heart disease, or osteoporosis, they have a high predisposition to the disease. Understanding family health history and predictive testing can help individuals prevent or manage these chronic conditions with proper guidance from a physician. Thus, the growing prevalence of such conditions globally, coupled with the adoption of preventive technologies, is aiding chronic disease management, thus driving the growth of this market.
-Laboratory-Testing-Market.webp "Medical Waste Management Market")
Click here to: Get Free Sample Copy of this report
Ease of Accessibility to DTC Tests and Promotion to Consumers Drives the Market growth
Over the last few years, consumers have been actively participating in the decisions affecting their health, enabling people to be informed of their health and lead healthy lifestyles. Clinical testing or laboratory tests are an important part of healthcare. Earlier, individuals were restricted by the laws and regulations, and tests could be ordered only after consulting a physician. After the emergence of DTC tests and the authorities' approvals, consumers can directly order the tests. These tests can be ordered online or bought from pharmacies without any prescription, making them easy to access for consumers. The easy and non-invasive sampling methods of DTC tests also attract customers.
Companies operating in this market are conducting marketing campaigns and advertisements to interest consumers and inform them about the benefits of DTC tests. This encourages customers to order these tests without needing to consult a physician. Consumers can get personalized information about their health, disease risk, and other traits and gain awareness of their genetic predisposition to illnesses.
Key Findings of the DTC Laboratory Testing Market Study:
Based on Application, the Genetic Testing Segment is Expected to Register the Highest CAGR During the Forecast Period
The growth of this segment is attributed to the rising appeal of DTC genetic testing to explore information regarding family health history and predictive testing, the launch of new DTC genetic tests for new applications, and increasing curiosity among people in developed countries regarding their ancestry and lineage. Genetic DTC tests identify individuals at risk of specific conditions to reduce mortality and morbidity through timely screening, surveillance, and prevention. For instance, in 2022, the WHO reported that around 41 million people succumbed to non-communicable or chronic diseases globally.
Based on Sample Type, in 2022, the Saliva Segment is Expected to Account for the Largest Share of the Market
The large market share of this segment is attributed to the benefits of saliva samples in DTC tests. Saliva sample collection is a simple, reliable, and non-invasive method and is convenient in sample packaging and transporting to the testing labs.
Asia Pacific: Fastest Growing Market
In 2022, North America is expected to account for the largest share of the global DTC laboratory testing market. However, Asia-Pacific is slated to register the highest CAGR during the forecast period. The factors driving the growth of the DTC laboratory testing market in Asia-Pacific are the increasing prevalence of infectious & chronic diseases and the increasing awareness in people regarding disease risk prediction and healthy lifestyle.
Key Players
The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments in leading industry market players over the past years. The key players profiled in the global DTC laboratory testing market are Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), EverlyWell, Inc. (U.S.), DirectLabs, LLC (U.S.), Ancestry.com, LLC (U.S.), 23andMe, Inc. (U.S.), MyMedLab, Inc. (U.S.), ANY LAB TEST NOW (U.S.), WellnessFx, Inc. (U.S.), LetsGetChecked, Inc. (U.S.), and Myriad Genetics, Inc. (U.S.).
Scope of the Report:
Direct to Consumer Laboratory Testing Market, by Application
Direct to Consumer Laboratory Testing Market, by Sample Type
Direct to Consumer Laboratory Testing Market, by Geography
Key questions answered in the report:
The DTC laboratory testing market covers the market size & forecasts of the applications, including genetic testing, COVID-19, cancer, diabetes testing, disease risk assessment testing, sexually transmitted disease testing, routine testing, complete blood count, CNS-related/neurological disease, thyroid stimulating hormone testing, and other applications. The DTC laboratory testing market studied in this report involves the value analysis of various segments and sub-segments of the DTC laboratory testing market at regional and country levels.
The global DTC laboratory testing market is projected to reach $14.61 billion by 2029, at a CAGR of 21.2% during the forecast period.
In 2022, the genetic testing segment is expected to account for the largest share of the DTC laboratory testing market. The rising appeal of DTC genetic testing to explore information regarding family health history and predictive testing, the launch of new DTC genetic tests for new applications, and the increasing curiosity among people in developed countries regarding their ancestry and lineage contribute to the growth of this segment.
Based on the sample type, the saliva segment is projected to create more traction as saliva sample collection is a simple, non-invasive, convenient technique in terms of sample packaging & transport.
Easy accessibility of DTC tests, the growing awareness regarding family health history and predictive testing, the increasing need for early disease diagnosis, and the rising geriatric population that prefers convenient care are expected to propel the global DTC laboratory testing market. Moreover, the increasing adoption of telehealth offers an opportunity to players operating in the DTC laboratory testing market.
The key players operating in the global DTC laboratory testing market are Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), EverlyWell, Inc. (U.S.), DirectLabs, LLC (U.S.), Ancestry.com, LLC (U.S.), 23andMe, Inc. (U.S.), MyMedLab, Inc. (U.S.), ANY LAB TEST NOW (U.S.), WellnessFx, Inc. (U.S.), LetsGetChecked, Inc. (U.S.), and Myriad Genetics, Inc. (U.S.).
The emerging Asian-Pacific countries are projected to offer significant growth opportunities for the vendors in this market owing to the increasing prevalence of infectious and chronic diseases and the increasing awareness in people regarding disease risk prediction and a healthy lifestyle.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Increasing Awareness Regarding Predictive Testing and Family Health History
4.2.2. Easy Accessibility of DTC Tests
4.2.3. Increasing Prevalence of Chronic and Infectious Diseases
4.3. Restraints
4.3.1. Sample Integrity and Interference Issues
4.4. Opportunities
4.4.1. Growing Adoption of Telehealth
4.5. Challenges
4.5.1. Misinterpretation of Test Results
4.5.2 Genetic Data Privacy Concerns
4.6. Impact Analysis of COVID-19
5. DTC Laboratory Testing Market, by Application
5.1. Introduction
5.2. Genetic Testing
5.3. COVID-19
5.4. Cancer
5.5. Diabetes testing
5.6. Disease Risk Assessment Testing
5.7. Sexually Transmitted Disease Testing
5.8. Routine Testing
5.9. Complete Blood Count
5.10. Diabetes testing
5.11. CNS-related/Neurological Disease
5.12. Thyroid Stimulating Hormone
5.13. Other Applications
6. DTC Laboratory Testing Market, by Sample Type
6.1. Introduction
6.2. Saliva
6.3. Urine
6.4. Blood
6.3. Other Sample Types
7. DTC Laboratory Testing Market, by Geography
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Spain
7.3.5. Italy
7.3.6. Rest of Europe (RoE)
7.4. Asia-Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia-Pacific (RoAPAC)
7.5. Latin America
7.5.1. Brazil
7.5.2. Mexico
7.5.3. Argentina
7.5.4. Rest of Latin America (RoLATM)
7.6. Middle East & Africa
8. Competitive Landscape
8.1. Introduction
8.2. Key Growth Strategies
8.3. Competitive Benchmarking
9. Company Profiles (Business Overview, Financial Snapshot, Product Benchmarking, and Strategic Developments)
9.1. Quest Diagnostics Incorporated
9.2. Laboratory Corporation of America Holdings
9.3. EverlyWell, Inc.
9.4. DirectLabs, LLC
9.5. Ancestry.com, LLC
9.6. CareDx, Inc.
9.7. 23andMe, Inc.
9.8. MyMedLab, Inc.
9.9. ANY LAB TEST NOW
9.10. WellnessFx, Inc.
9.11. LetsGetChecked, Inc.
9.12. Myriad Genetics, Inc.
10. Appendix
10.1. Questionnaire
10.2. Available Customization
List of Tables
Table 1 Global DTC Laboratory Testing Market Drivers: Impact Analysis (2022–2029)
Table 2 Global DTC Laboratory Testing Market Restraints: Impact Analysis (2022–2029)
Table 3 Global DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 4 Global DTC Laboratory Testing Market Size for Genetic Testing, by Country/Region, 2020–2029 (USD Million)
Table 5 Global DTC Laboratory Testing Market Size for COVID-19, by Country/Region, 2020–2029 (USD Million)
Table 6 Global DTC Laboratory Testing Market Size for Cancer, by Country/Region, 2020–2029 (USD Million)
Table 7 Global DTC Laboratory Testing Market Size for Diabetes Testing, by Country/Region, 2020–2029 (USD Million)
Table 8 Global DTC Laboratory Testing Market Size for Disease Risk Assessment Testing, by Country/Region, 2020–2029 (USD Million)
Table 9 Global DTC Laboratory Testing Market Size for Sexually Transmitted Disease Testing, by Country/Region, 2020–2029 (USD Million)
Table 10 Global DTC Laboratory Testing Market Size for Routine Testing, by Country/Region, 2020–2029 (USD Million)
Table 11 Global DTC Laboratory Testing Market Size for Complete Blood Count, by Country/Region, 2020–2029 (USD Million)
Table 12 Global DTC Laboratory Testing Market Size for CNS-related/Neurological Disease, by Country/Region, 2020–2029 (USD Million)
Table 13 Global DTC Laboratory Testing Market Size for Thyroid Stimulating Hormone, by Country/Region, 2020–2029 (USD Million)
Table 14 Global DTC Laboratory Testing Market Size for Other Applications, by Country/Region, 2020–2029 (USD Million)
Table 15 Global DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 16 Global DTC Laboratory Testing Market Size for Saliva, by Country/Region, 2020–2029 (USD Million)
Table 17 Global DTC Laboratory Testing Market Size for Urine, by Country/Region, 2020–2029 (USD Million)
Table 18 Global DTC Laboratory Testing Market Size for Blood, by Country/Region, 2020–2029 (USD Million)
Table 19 Global DTC Laboratory Testing Market Size for Other Sample Types, by Country/Region, 2020–2029 (USD Million)
Table 20 Global DTC Laboratory Testing Market Size, by Country/Region, 2020–2029 (USD Million)
Table 21 North America: DTC Laboratory Testing Market Size, by Country, 2020–2029 (USD Million)
Table 22 North America: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 23 North America: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 24 U.S.: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 25 U.S.: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 26 Canada: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 27 Canada: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 28 Europe: DTC Laboratory Testing Market Size, by Country/Region, 2020–2029 (USD Million)
Table 29 Europe: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 30 Europe: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 31 U.K.: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 32 U.K.: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 33 Germany: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 34 Germany: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 35 France: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 36 France: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 37 Spain: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 38 Spain: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 39 Italy: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 40 Italy: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 41 RoE: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 42 RoE: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 43 Asia-Pacific: DTC Laboratory Testing Market Size, by Country/Region, 2020–2029 (USD Million)
Table 44 Asia-Pacific: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 45 Asia-Pacific: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 46 Japan: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 47 Japan: DTC Laboratory Testing Market Size, by Sample type, 2020–2029 (USD Million)
Table 48 China: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 49 China: DTC Laboratory Testing Market Size, by Sample type, 2020–2029 (USD Million)
Table 50 India: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 51 India: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 52 RoAPAC: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 53 RoAPAC: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 54 Latin America: DTC Laboratory Testing Market Size, by Country/Region, 2020–2029 (USD Million)
Table 55 Latin America: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 56 Latin America: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 57 Brazil: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 58 China: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 59 Mexico: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 60 Mexico: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 61 Argentina: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 62 Argentina: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 63 RoLATM: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 64 RoLATM: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 65 Middle East & Africa: DTC Laboratory Testing Market Size, by Application, 2020–2029 (USD Million)
Table 66 Middle East & Africa: DTC Laboratory Testing Market Size, by Sample Type, 2020–2029 (USD Million)
Table 67 Recent Developments, by Company, 2020–2022
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Market Dynamics
Figure 8 Global DTC Laboratory Testing Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 9 Global DTC Laboratory Testing Market Size, by Sample Type, 2022 Vs. 2029 (USD Million)
Figure 10 Global DTC Laboratory Testing Market, by Geography
Figure 11 North America: DTC Laboratory Testing Market Snapshot
Figure 12 Europe: DTC Laboratory Testing Market Snapshot
Figure 13 Asia-Pacific: DTC Laboratory Testing Market Snapshot
Figure 14 Latin America: DTC Laboratory Testing Market Snapshot
Figure 15 Key Growth Strategies Adopted by Leading Players, 2019–2022
Figure 16 DTC Laboratory Testing Market: Competitive Benchmarking (Based on Product)
Figure 17 DTC Laboratory Testing Market: Competitive Benchmarking (Based on Geography)
Figure 18 Quest Diagnostics Incorporated (BD): Financial Snapshot (2021)
Figure 19 Laboratory Corporation of America Holdings: Financial Snapshot (2021)
Figure 20 23andMe, Inc.: Financial Snapshot (2021)
Figure 21 Myriad Genetics, Inc.: Financial Snapshot (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Jan-2023
Published Date: Jan-2023
Published Date: Jan-2023
